Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Vfend Tablets 200mg


Contraindicated
Reproductive toxicity in animals

Contraindicated
Vfend Tablets 200mg :
Type Medicine Authorised
Originator B
Agent Droguerie Fattal
Distributor Droguerie Fattal
Laboratory Pfizer
Responsible Party Pfizer Ltd
Origin UK
Manufacturer R-Pharm Germany GmbH
Origin Germany
ATC J02AC03
Revision Date 09/10/2008

Your comment will appear shortly after approval

Vfend Tablets 200mg :

Revision Date : 23/06/2014


Effect Frequency
Abdominal pain Very Common
Acute kidney injury Common
Acute respiratory distress syndrome Common
Adrenal insufficiency Uncommon
Agitation Common
Agranulocytosis Common
Alanine aminotransferase abnormal Not known
Alopecia Common
Anaemia Common
Anaphylactoid reactions Uncommon
Angioedema (Angioneurotic oedema) (Quincke oedema) Uncommon
Anxiety Common
Arrhythmia Not known
Arrhythmia supraventricular Common
Arthritis Uncommon
AST abnormal Not known
Asthenia Common
Ataxia Uncommon
Atrioventricular block complete Rare
Back pain Common
Blepharitis Uncommon
Blood alkaline phosphatase abnormal Not known
Blood bilirubin abnormal Not known
Blood bilirubin increased Not known
Blood cholesterol increased Uncommon
Blood creatinine increased Common
Blood lactate dehydrogenase abnormal Not known
Blood urea increased Uncommon
Bone marrow failure Uncommon
Bradycardia Common
Bundle branch block Rare
Cerebral oedema (Brain oedema) Uncommon
Cheilitis Common
Chest pain Common
Chills Common
Cholecystitis Uncommon
Cholelithiasis (Calculus biliary) (Gallstones) Uncommon
Chromatopsia Very Common
Confusional state Common
Constipation Common
Corneal opacity Rare
Cutaneous lupus erythematosus Not known
Depression Common
Dermatitis allergic Uncommon
Dermatitis exfoliative Common
Diarrhoea (Diarrhea) Very Common
Diplopia Uncommon
Disseminated intravascular coagulation Uncommon
Dizziness Common
Duodenitis Uncommon
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) Uncommon
Dyspepsia Common
ECG QT prolonged Uncommon
Eczema Uncommon
Encephalopathy Uncommon
Eosinophilia Uncommon
Erythema Common
Erythema multiforme Uncommon
Extrapyramidal disorder Uncommon
Face oedema Common
Fixed drug eruption Rare
Gamma-GT abnormal Not known
Gastroenteritis Common
Gingivitis Common
Glossitis Uncommon
Guillain-Barre syndrome Rare
Haematuria (Hematuria) Common
Hallucination Common
Headache Very Common
Hepatic encephalopathy Rare
Hepatic enzyme increased Not known
Hepatic failure (Hepatic insufficiency) (Liver failure) Uncommon
Hepatitis Common
Hepatomegaly Uncommon
Hepatotoxicity (liver toxicity) Not known
Hypersensitivity Common
Hyperthyroidism Rare
Hypertonia Common
Hypoacusis Uncommon
Hypoesthesia Uncommon
Hypoglycaemia Common
Hypokalaemia Common
Hyponatraemia (Hyponatremia) Common
Hypotension Common
Hypothyroidism Uncommon
Influenza-like illness Common
Injection site reaction Uncommon
Insomnia Common
Jaundice Common
Jaundice cholestatic (Cholestatic icterus) Common
Leucopenia (Leukopenia) Uncommon
Liver function test abnormal Very Common
Lyell Syndrome (Toxic epidermal necrolysis) Uncommon
Lymphadenopathy Uncommon
Lymphangitis Uncommon
Maculopapular rash Common
Nausea Very Common
Nephritis Uncommon
Neuropathy peripheral Uncommon
Nodal rhythm Rare
Nystagmus Uncommon
Oculogyric crisis Uncommon
Oedema peripheral Very Common
Optic atrophy Rare
Optic nerve disorder Uncommon
Optic neuritis Uncommon
Pancreatitis Uncommon
Pancytopenia Common
Papilloedema Uncommon
Paraesthesia (paresthesia) Common
Periostitis Not known
Peritonitis Uncommon
Phlebitis Common
Photophobia Very Common
Photosensitivity reaction Common
Proteinuria Uncommon
Pruritus Common
Pseudomembranous colitis Uncommon
Pseudoporphyria Rare
Psoriasis Uncommon
Pulmonary oedema Common
Purpura Uncommon
Pyrexia Very Common
Rash macular Uncommon
Rash papular Uncommon
Renal tubular necrosis Uncommon
Respiratory distress Very Common
Retinal haemorrhage Common
Retinogram abnormal Not known
scleritis Uncommon
Seizures Common
Sinusitis Common
Skin rash Very Common
Somnolence Common
Squamous cell carcinoma of skin Not known
Stevens-Johnson syndrome Uncommon
Supraventricular tachycardia Uncommon
Swollen tongue Uncommon
Syncope Common
Tachycardia Common
Thrombocytopenia (Thrombopenia) Common
Thrombophlebitis Uncommon
Tinnitus Uncommon
Torsade de pointes Rare
Tremor Common
Urticaria Uncommon
Ventricular extrasystoles Uncommon
Ventricular fibrillation Uncommon
Ventricular tachycardia Uncommon
Vertigo Uncommon
Vision blurred Very Common
Visual disturbance Very Common
Vomiting Very Common

Different Units By MoH Code

Revision Date : 06/05/2022

Revision Date : 06/05/2022

Vfend Tablets 200mg  MoH 5184 :
Form Tablet, Film-Coated
Packaging Blisters (Al/PVC)
Package Size Box of 30
Strength 200mg
Public Price 887012 L.L.
Stratum E1
NSSF ✔
Quarantine ✔
Reg. Number 23878/07
Submission date 01/01/2007
Registration Year 2007


Price Comparison

● Country: Denmark
● Package Size: 30
● Public Price: 21053.1 DKK ( 51,811,047.51 LBP )
● Pack size unit used: 30
● Cost/Unit: 701,77 DKK ( 1,725,139.97 LBP )
● Reference: Danish Medicine Agency
● Pricing Date: 19/05/2021
● Type: Medicine Non Marketed

● Country: Germany
● Package Size: 30
● Public Price: 1969.47 EUR ( 36,198,957.07 LBP )
● Pack size unit used: 30
● Cost/Unit: 65,649 EUR ( 1,194,703.25 LBP )
● Pricing Date: 15/05/2021
● Type: Medicine Authorised

● Country: Italy
● Package Size: 28UNITA
● Public Price: 1745.38 EUR ( 32,080,171.67 LBP )
● Pack size unit used: 28
● Cost/Unit: 62,335 EUR ( 1,139,563.10 LBP )
● Pricing Date: 15/01/2021
● Type: Medicine Authorised

● Country: Switzerland
● Package Size: 28
● Public Price: 1704.1 CHF ( 29,072,372.03 LBP )
● Pack size unit used: 28
● Cost/Unit: 60,8607 CHF ( 1,023,615.00 LBP )
● Exfactory Price: 1497.71 CHF
● Pricing Date: 04/04/2021
● Type: Medicine Authorised

● Country: UK
● Package Size: 28
● Public Price: 1102.74 GBP ( 22,221,060.11 LBP )
● Pack size unit used: 28
● Cost/Unit: 39,3836 GBP ( 785,880.03 LBP )
● Reference: DMD
● Pricing Date: 08/03/2021
● Type: Medicine Authorised

● Country: Qatar
● Package Size: 30
● Public Price: 5679 QAR ( 23,571,030.24 LBP )
● Pack size unit used: 30
● Cost/Unit: 189,3 QAR ( 784,455.84 LBP )
● Pharmacy Price: 4664.7317358356 QAR ( 19361248.95349 LBP )
● Pricing Date: 28/01/2021
● Type: Medicine Authorised

● Country: Czech Republic
● Package Size: 14
● Public Price: 15477.95 CZK ( 10,691,548.74 LBP )
● Pack size unit used: 14
● Cost/Unit: 1105,5679 CZK ( 763,289.80 LBP )
● Reference: SUKL
● Pricing Date: 28/02/2020
● Type: Medicine Authorised

● Country: Kuweit
● Package Size: Boîte de 30
● Public Price: 465.91 KWD ( 23,095,195.97 LBP )
● Pack size unit used: 30
● Cost/Unit: 15,5303 KWD ( 743,551.20 LBP )
● Pharmacy Price: 393.61 KWD ( 19511279.1888 LBP )
● Pricing Date: 07/02/2021
● Type: Medicine Authorised

● Country: Abu Dhabi
● Package Size: 30
● Public Price: 5306.5 AED ( 21,814,809.24 LBP )
● Pack size unit used: 30
● Cost/Unit: 176,8833 AED ( 723,528.96 LBP )
● Pharmacy Price: 4520.41 AED ( 18583224.6936 LBP )
● Pricing Date: 27/01/2021
● Type: Medicine Authorised

● Country: UAE
● Package Size: 30's Blister
● Public Price: 5306.5 AED ( 21,814,809.24 LBP )
● Pack size unit used: 30
● Cost/Unit: 176,8833 AED ( 723,528.96 LBP )
● Pharmacy Price: 4520.41 AED ( 18583224.6936 LBP )
● Pricing Date: 21/08/2019
● Type: Medicine Authorised

● Country: Spain
● Package Size: 28
● Public Price: 1097.02 EUR ( 20,163,282.45 LBP )
● Pack size unit used: 28
● Cost/Unit: 39,1793 EUR ( 716,821.95 LBP )
● Reference: Agencia Española de Medicamentos y Productos Sanitarios
● Pricing Date: 06/05/2021
● Type: Medicine Non Marketed

● Country: Bahrain
● Package Size: 30
● Public Price: 504.74 BHD ( 20,250,557.45 LBP )
● Pack size unit used: 30
● Cost/Unit: 16,8247 BHD ( 641,932.32 LBP )
● Reference: nhra
● Pricing Date: 09/02/2021
● Type: Medicine Authorised

● Country: Oman
● Package Size: 30
● Public Price: 478.34 OMR ( 18,799,001.17 LBP )
● Pack size unit used: 30
● Cost/Unit: 15,9447 OMR ( 589,507.50 LBP )
● Pricing Date: 19/02/2021
● Type: Medicine Authorised

● Country: Ireland
● Package Size: 28
● Public Price: 886.79 EUR ( 16,299,244.54 LBP )
● Pack size unit used: 28
● Cost/Unit: 31,6711 EUR ( 569,781.55 LBP )
● Pricing Date: 08/10/2020
● Type: Medicine Authorised

● Country: Jordan
● Package Size: 30
● Public Price: 797.18 JOD ( 17,011,972.66 LBP )
● Pack size unit used: 30
● Cost/Unit: 26,5727 JOD ( 554,844.94 LBP )
● Pharmacy Price: 766.52 JOD ( 16357682.4388 LBP )
● Reference: JFDA
● Pricing Date: 02/01/2021
● Type: Medicine Authorised

● Country: KSA
● Package Size: 30
● Public Price: 3887.95 SAR ( 15,669,915.92 LBP )
● Pack size unit used: 30
● Cost/Unit: 129,5983 SAR ( 519,919.02 LBP )
● Reference: sfda
● Pricing Date: 16/01/2021
● Type: Medicine Authorised

● Country: Cyprus
● Package Size: 14
● Public Price: 315.68 EUR ( 5,802,214.18 LBP )
● Pack size unit used: 14
● Cost/Unit: 22,5486 EUR ( 404,361.10 LBP )
● Reference: Cyprus Minister of Health
● Pricing Date: 24/03/2021
● Type: Medicine Authorised

● Country: Iceland
● Package Size: 30
● Public Price: 108299 ISK ( 12,006,027.14 LBP )
● Pack size unit used: 30
● Cost/Unit: 3609,9667 ISK ( 400,093.74 LBP )
● Pharmacy Price: 83100 ISK ( 9212466 LBP )
● Reference: Icelandic Medicines Agency
● Pricing Date: 01/04/2020
● Type: Medicine Authorised

● Country: Greece
● Package Size: 14
● Public Price: 282.81 EUR ( 5,198,061.94 LBP )
● Pack size unit used: 14
● Cost/Unit: 20,2007 EUR ( 367,601.00 LBP )
● Exfactory Price: 234.69 EUR
● Pharmacy Price: 238.21 EUR ( 4378311.7105 LBP )
● Reference: National Organization for Medicines
● Pricing Date: 20/08/2020
● Type: Medicine Authorised

● Country: Belgium
● Package Size: 28
● Public Price: 532.79 EUR ( 9,792,706.84 LBP )
● Pack size unit used: 28
● Cost/Unit: 19,0282 EUR ( 349,220.95 LBP )
● Reference: cbip
● Pricing Date: 27/11/2020
● Type: Medicine Authorised

● Country: Norway
● Package Size: x30stk
● Public Price: 5913 NOK ( 10,231,086.51 LBP )
● Pack size unit used: 30
● Cost/Unit: 197,1 NOK ( 340,863.19 LBP )
● Pharmacy Price: 4609.19 NOK ( 7975143.1813 LBP )
● Reference: Norwegian Medicine Agency
● Pricing Date: 01/04/2020
● Type: Medicine Authorised

● Country: Sweden
● Package Size: 28
● Public Price: 5162.28 SEK ( 9,292,671.85 LBP )
● Pack size unit used: 28
● Cost/Unit: 184,3671 SEK ( 331,220.24 LBP )
● Pharmacy Price: 5004.44 SEK ( 9008542.4884 LBP )
● Pricing Date: 23/04/2020
● Type: Medicine Authorised

● Country: France
● Package Size: 28
● Public Price: 437.63 EUR ( 8,043,661.28 LBP )
● Pack size unit used: 28
● Cost/Unit: 15,6296 EUR ( 275,700.75 LBP )
● Reference: ansm
● Pricing Date: 15/05/2021
● Type: Medicine Authorised

● Country: Egypt
● Package Size: 10
● Public Price: 1950 EGP ( 1,872,195.00 LBP )
● Pack size unit used: 10
● Cost/Unit: 195 EGP ( 187,219.50 LBP )
● Pricing Date: 20/11/2019
● Type: Medicine Authorised

● Country: Finland
● Package Size: 56
● Public Price: 609.88 EUR ( 11,209,624.89 LBP )
● Pack size unit used: 56
● Cost/Unit: 10,8907 EUR ( 183,800.50 LBP )
● Reference: Kela
● Pricing Date: 22/04/2021
● Type: Medicine Authorised

● Country: Turkey
● Package Size: 30
● Public Price: 2145.93 TRY ( 4,121,666.29 LBP )
● Pack size unit used: 30
● Cost/Unit: 71,531 TRY ( 136,368.99 LBP )
● Pricing Date: 28/10/2020
● Type: Medicine Authorised

● Country: Lebanon
● Form: Tablet, Film-Coated
● Package Size: Box of 30
● Public Price: 887012 LBP ( 887,012.00 LBP )
● Pack size unit used: 30
● Cost/Unit: 29567,07 LBP ( 29,567.00 LBP )
● Pricing Date: 10/01/2024

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries

Note

Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 701,77 DKK ( 1,725,139.97 LBP )
● Cost/Day: 2807,08 DKK ( 6,907,942.79 LBP )
● Cost/Month: 84212,4 DKK ( 207,243,205.64 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 701,77 DKK ( 1,725,139.97 LBP )
● Cost/Day: 2807,08 DKK ( 6,907,942.79 LBP )
● Cost/Month: 84212,4 DKK ( 207,243,205.64 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 701,77 DKK ( 1,725,139.97 LBP )
● Cost/Day: 2807,08 DKK ( 6,907,942.79 LBP )
● Cost/Month: 84212,4 DKK ( 207,243,205.64 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 701,77 DKK ( 1,725,139.97 LBP )
● Cost/Day: 2807,08 DKK ( 6,907,942.79 LBP )
● Cost/Month: 84212,4 DKK ( 207,243,205.64 LBP )
Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 65,649 EUR ( 1,194,703.25 LBP )
● Cost/Day: 262,6 EUR ( 4,815,573.10 LBP )
● Cost/Month: 7878 EUR ( 144,798,033.90 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 65,649 EUR ( 1,194,703.25 LBP )
● Cost/Day: 262,6 EUR ( 4,815,573.10 LBP )
● Cost/Month: 7878 EUR ( 144,798,033.90 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 65,649 EUR ( 1,194,703.25 LBP )
● Cost/Day: 262,6 EUR ( 4,815,573.10 LBP )
● Cost/Month: 7878 EUR ( 144,798,033.90 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 65,649 EUR ( 1,194,703.25 LBP )
● Cost/Day: 262,6 EUR ( 4,815,573.10 LBP )
● Cost/Month: 7878 EUR ( 144,798,033.90 LBP )
Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 62,335 EUR ( 1,139,563.10 LBP )
● Cost/Day: 249,34 EUR ( 4,576,632.45 LBP )
● Cost/Month: 7480,2 EUR ( 137,482,774.00 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 62,335 EUR ( 1,139,563.10 LBP )
● Cost/Day: 249,34 EUR ( 4,576,632.45 LBP )
● Cost/Month: 7480,2 EUR ( 137,482,774.00 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 62,335 EUR ( 1,139,563.10 LBP )
● Cost/Day: 249,34 EUR ( 4,576,632.45 LBP )
● Cost/Month: 7480,2 EUR ( 137,482,774.00 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 62,335 EUR ( 1,139,563.10 LBP )
● Cost/Day: 249,34 EUR ( 4,576,632.45 LBP )
● Cost/Month: 7480,2 EUR ( 137,482,774.00 LBP )
Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 60,8607 CHF ( 1,023,615.00 LBP )
● Cost/Day: 243,44 CHF ( 4,145,640.75 LBP )
● Cost/Month: 7303,2 CHF ( 124,591,005.75 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 60,8607 CHF ( 1,023,615.00 LBP )
● Cost/Day: 243,44 CHF ( 4,145,640.75 LBP )
● Cost/Month: 7303,2 CHF ( 124,591,005.75 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 60,8607 CHF ( 1,023,615.00 LBP )
● Cost/Day: 243,44 CHF ( 4,145,640.75 LBP )
● Cost/Month: 7303,2 CHF ( 124,591,005.75 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 60,8607 CHF ( 1,023,615.00 LBP )
● Cost/Day: 243,44 CHF ( 4,145,640.75 LBP )
● Cost/Month: 7303,2 CHF ( 124,591,005.75 LBP )
Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 39,3836 GBP ( 785,880.03 LBP )
● Cost/Day: 157,53 GBP ( 3,163,670.89 LBP )
● Cost/Month: 4725,9 GBP ( 95,212,388.25 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 39,3836 GBP ( 785,880.03 LBP )
● Cost/Day: 157,53 GBP ( 3,163,670.89 LBP )
● Cost/Month: 4725,9 GBP ( 95,212,388.25 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 39,3836 GBP ( 785,880.03 LBP )
● Cost/Day: 157,53 GBP ( 3,163,670.89 LBP )
● Cost/Month: 4725,9 GBP ( 95,212,388.25 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 39,3836 GBP ( 785,880.03 LBP )
● Cost/Day: 157,53 GBP ( 3,163,670.89 LBP )
● Cost/Month: 4725,9 GBP ( 95,212,388.25 LBP )
Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 189,3 QAR ( 784,455.84 LBP )
● Cost/Day: 757,2 QAR ( 3,141,973.92 LBP )
● Cost/Month: 22716 QAR ( 94,284,120.96 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 189,3 QAR ( 784,455.84 LBP )
● Cost/Day: 757,2 QAR ( 3,141,973.92 LBP )
● Cost/Month: 22716 QAR ( 94,284,120.96 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 189,3 QAR ( 784,455.84 LBP )
● Cost/Day: 757,2 QAR ( 3,141,973.92 LBP )
● Cost/Month: 22716 QAR ( 94,284,120.96 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 189,3 QAR ( 784,455.84 LBP )
● Cost/Day: 757,2 QAR ( 3,141,973.92 LBP )
● Cost/Month: 22716 QAR ( 94,284,120.96 LBP )
Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 1105,5679 CZK ( 763,289.80 LBP )
● Cost/Day: 4422,27 CZK ( 3,054,540.72 LBP )
● Cost/Month: 132668,1 CZK ( 91,641,747.68 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 1105,5679 CZK ( 763,289.80 LBP )
● Cost/Day: 4422,27 CZK ( 3,054,540.72 LBP )
● Cost/Month: 132668,1 CZK ( 91,641,747.68 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 1105,5679 CZK ( 763,289.80 LBP )
● Cost/Day: 4422,27 CZK ( 3,054,540.72 LBP )
● Cost/Month: 132668,1 CZK ( 91,641,747.68 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 1105,5679 CZK ( 763,289.80 LBP )
● Cost/Day: 4422,27 CZK ( 3,054,540.72 LBP )
● Cost/Month: 132668,1 CZK ( 91,641,747.68 LBP )
Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 15,5303 KWD ( 743,551.20 LBP )
● Cost/Day: 62,12 KWD ( 3,073,344.96 LBP )
● Cost/Month: 1863,6 KWD ( 92,349,059.04 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 15,5303 KWD ( 743,551.20 LBP )
● Cost/Day: 62,12 KWD ( 3,073,344.96 LBP )
● Cost/Month: 1863,6 KWD ( 92,349,059.04 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 15,5303 KWD ( 743,551.20 LBP )
● Cost/Day: 62,12 KWD ( 3,073,344.96 LBP )
● Cost/Month: 1863,6 KWD ( 92,349,059.04 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 15,5303 KWD ( 743,551.20 LBP )
● Cost/Day: 62,12 KWD ( 3,073,344.96 LBP )
● Cost/Month: 1863,6 KWD ( 92,349,059.04 LBP )
Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 176,8833 AED ( 723,528.96 LBP )
● Cost/Day: 707,53 AED ( 2,906,448.72 LBP )
● Cost/Month: 21225,9 AED ( 87,255,126.00 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 176,8833 AED ( 723,528.96 LBP )
● Cost/Day: 707,53 AED ( 2,906,448.72 LBP )
● Cost/Month: 21225,9 AED ( 87,255,126.00 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 176,8833 AED ( 723,528.96 LBP )
● Cost/Day: 707,53 AED ( 2,906,448.72 LBP )
● Cost/Month: 21225,9 AED ( 87,255,126.00 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 176,8833 AED ( 723,528.96 LBP )
● Cost/Day: 707,53 AED ( 2,906,448.72 LBP )
● Cost/Month: 21225,9 AED ( 87,255,126.00 LBP )
Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 176,8833 AED ( 723,528.96 LBP )
● Cost/Day: 707,53 AED ( 2,906,448.72 LBP )
● Cost/Month: 21225,9 AED ( 87,255,126.00 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 176,8833 AED ( 723,528.96 LBP )
● Cost/Day: 707,53 AED ( 2,906,448.72 LBP )
● Cost/Month: 21225,9 AED ( 87,255,126.00 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 176,8833 AED ( 723,528.96 LBP )
● Cost/Day: 707,53 AED ( 2,906,448.72 LBP )
● Cost/Month: 21225,9 AED ( 87,255,126.00 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 176,8833 AED ( 723,528.96 LBP )
● Cost/Day: 707,53 AED ( 2,906,448.72 LBP )
● Cost/Month: 21225,9 AED ( 87,255,126.00 LBP )
Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 39,1793 EUR ( 716,821.95 LBP )
● Cost/Day: 156,72 EUR ( 2,867,287.80 LBP )
● Cost/Month: 4701,6 EUR ( 86,404,615.05 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 39,1793 EUR ( 716,821.95 LBP )
● Cost/Day: 156,72 EUR ( 2,867,287.80 LBP )
● Cost/Month: 4701,6 EUR ( 86,404,615.05 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 39,1793 EUR ( 716,821.95 LBP )
● Cost/Day: 156,72 EUR ( 2,867,287.80 LBP )
● Cost/Month: 4701,6 EUR ( 86,404,615.05 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 39,1793 EUR ( 716,821.95 LBP )
● Cost/Day: 156,72 EUR ( 2,867,287.80 LBP )
● Cost/Month: 4701,6 EUR ( 86,404,615.05 LBP )
Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 16,8247 BHD ( 641,932.32 LBP )
● Cost/Day: 67,3 BHD ( 2,688,091.59 LBP )
● Cost/Month: 2019 BHD ( 81,003,834.63 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 16,8247 BHD ( 641,932.32 LBP )
● Cost/Day: 67,3 BHD ( 2,688,091.59 LBP )
● Cost/Month: 2019 BHD ( 81,003,834.63 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 16,8247 BHD ( 641,932.32 LBP )
● Cost/Day: 67,3 BHD ( 2,688,091.59 LBP )
● Cost/Month: 2019 BHD ( 81,003,834.63 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 16,8247 BHD ( 641,932.32 LBP )
● Cost/Day: 67,3 BHD ( 2,688,091.59 LBP )
● Cost/Month: 2019 BHD ( 81,003,834.63 LBP )
Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 15,9447 OMR ( 589,507.50 LBP )
● Cost/Day: 63,78 OMR ( 2,475,931.50 LBP )
● Cost/Month: 1913,4 OMR ( 75,181,856.50 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 15,9447 OMR ( 589,507.50 LBP )
● Cost/Day: 63,78 OMR ( 2,475,931.50 LBP )
● Cost/Month: 1913,4 OMR ( 75,181,856.50 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 15,9447 OMR ( 589,507.50 LBP )
● Cost/Day: 63,78 OMR ( 2,475,931.50 LBP )
● Cost/Month: 1913,4 OMR ( 75,181,856.50 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 15,9447 OMR ( 589,507.50 LBP )
● Cost/Day: 63,78 OMR ( 2,475,931.50 LBP )
● Cost/Month: 1913,4 OMR ( 75,181,856.50 LBP )
Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 31,6711 EUR ( 569,781.55 LBP )
● Cost/Day: 126,68 EUR ( 2,315,886.30 LBP )
● Cost/Month: 3800,4 EUR ( 69,844,190.00 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 31,6711 EUR ( 569,781.55 LBP )
● Cost/Day: 126,68 EUR ( 2,315,886.30 LBP )
● Cost/Month: 3800,4 EUR ( 69,844,190.00 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 31,6711 EUR ( 569,781.55 LBP )
● Cost/Day: 126,68 EUR ( 2,315,886.30 LBP )
● Cost/Month: 3800,4 EUR ( 69,844,190.00 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 31,6711 EUR ( 569,781.55 LBP )
● Cost/Day: 126,68 EUR ( 2,315,886.30 LBP )
● Cost/Month: 3800,4 EUR ( 69,844,190.00 LBP )
Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 26,5727 JOD ( 554,844.94 LBP )
● Cost/Day: 106,29 JOD ( 2,262,060.14 LBP )
● Cost/Month: 3188,7 JOD ( 68,032,525.72 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 26,5727 JOD ( 554,844.94 LBP )
● Cost/Day: 106,29 JOD ( 2,262,060.14 LBP )
● Cost/Month: 3188,7 JOD ( 68,032,525.72 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 26,5727 JOD ( 554,844.94 LBP )
● Cost/Day: 106,29 JOD ( 2,262,060.14 LBP )
● Cost/Month: 3188,7 JOD ( 68,032,525.72 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 26,5727 JOD ( 554,844.94 LBP )
● Cost/Day: 106,29 JOD ( 2,262,060.14 LBP )
● Cost/Month: 3188,7 JOD ( 68,032,525.72 LBP )
Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 129,5983 SAR ( 519,919.02 LBP )
● Cost/Day: 518,39 SAR ( 2,087,736.84 LBP )
● Cost/Month: 15551,7 SAR ( 62,676,439.38 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 129,5983 SAR ( 519,919.02 LBP )
● Cost/Day: 518,39 SAR ( 2,087,736.84 LBP )
● Cost/Month: 15551,7 SAR ( 62,676,439.38 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 129,5983 SAR ( 519,919.02 LBP )
● Cost/Day: 518,39 SAR ( 2,087,736.84 LBP )
● Cost/Month: 15551,7 SAR ( 62,676,439.38 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 129,5983 SAR ( 519,919.02 LBP )
● Cost/Day: 518,39 SAR ( 2,087,736.84 LBP )
● Cost/Month: 15551,7 SAR ( 62,676,439.38 LBP )
Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 22,5486 EUR ( 404,361.10 LBP )
● Cost/Day: 90,19 EUR ( 1,654,204.50 LBP )
● Cost/Month: 2705,7 EUR ( 49,718,035.25 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 22,5486 EUR ( 404,361.10 LBP )
● Cost/Day: 90,19 EUR ( 1,654,204.50 LBP )
● Cost/Month: 2705,7 EUR ( 49,718,035.25 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 22,5486 EUR ( 404,361.10 LBP )
● Cost/Day: 90,19 EUR ( 1,654,204.50 LBP )
● Cost/Month: 2705,7 EUR ( 49,718,035.25 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 22,5486 EUR ( 404,361.10 LBP )
● Cost/Day: 90,19 EUR ( 1,654,204.50 LBP )
● Cost/Month: 2705,7 EUR ( 49,718,035.25 LBP )
Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 3609,9667 ISK ( 400,093.74 LBP )
● Cost/Day: 14439,87 ISK ( 1,600,707.54 LBP )
● Cost/Month: 433196,1 ISK ( 48,024,108.56 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 3609,9667 ISK ( 400,093.74 LBP )
● Cost/Day: 14439,87 ISK ( 1,600,707.54 LBP )
● Cost/Month: 433196,1 ISK ( 48,024,108.56 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 3609,9667 ISK ( 400,093.74 LBP )
● Cost/Day: 14439,87 ISK ( 1,600,707.54 LBP )
● Cost/Month: 433196,1 ISK ( 48,024,108.56 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 3609,9667 ISK ( 400,093.74 LBP )
● Cost/Day: 14439,87 ISK ( 1,600,707.54 LBP )
● Cost/Month: 433196,1 ISK ( 48,024,108.56 LBP )
Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 20,2007 EUR ( 367,601.00 LBP )
● Cost/Day: 80,8 EUR ( 1,470,404.00 LBP )
● Cost/Month: 2424 EUR ( 44,553,241.20 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 20,2007 EUR ( 367,601.00 LBP )
● Cost/Day: 80,8 EUR ( 1,470,404.00 LBP )
● Cost/Month: 2424 EUR ( 44,553,241.20 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 20,2007 EUR ( 367,601.00 LBP )
● Cost/Day: 80,8 EUR ( 1,470,404.00 LBP )
● Cost/Month: 2424 EUR ( 44,553,241.20 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 20,2007 EUR ( 367,601.00 LBP )
● Cost/Day: 80,8 EUR ( 1,470,404.00 LBP )
● Cost/Month: 2424 EUR ( 44,553,241.20 LBP )
Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 19,0282 EUR ( 349,220.95 LBP )
● Cost/Day: 76,11 EUR ( 1,396,883.80 LBP )
● Cost/Month: 2283,3 EUR ( 41,961,654.15 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 19,0282 EUR ( 349,220.95 LBP )
● Cost/Day: 76,11 EUR ( 1,396,883.80 LBP )
● Cost/Month: 2283,3 EUR ( 41,961,654.15 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 19,0282 EUR ( 349,220.95 LBP )
● Cost/Day: 76,11 EUR ( 1,396,883.80 LBP )
● Cost/Month: 2283,3 EUR ( 41,961,654.15 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 19,0282 EUR ( 349,220.95 LBP )
● Cost/Day: 76,11 EUR ( 1,396,883.80 LBP )
● Cost/Month: 2283,3 EUR ( 41,961,654.15 LBP )
Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 197,1 NOK ( 340,863.19 LBP )
● Cost/Day: 788,4 NOK ( 1,363,452.76 LBP )
● Cost/Month: 23652 NOK ( 40,924,346.04 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 197,1 NOK ( 340,863.19 LBP )
● Cost/Day: 788,4 NOK ( 1,363,452.76 LBP )
● Cost/Month: 23652 NOK ( 40,924,346.04 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 197,1 NOK ( 340,863.19 LBP )
● Cost/Day: 788,4 NOK ( 1,363,452.76 LBP )
● Cost/Month: 23652 NOK ( 40,924,346.04 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 197,1 NOK ( 340,863.19 LBP )
● Cost/Day: 788,4 NOK ( 1,363,452.76 LBP )
● Cost/Month: 23652 NOK ( 40,924,346.04 LBP )
Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 184,3671 SEK ( 331,220.24 LBP )
● Cost/Day: 737,47 SEK ( 1,326,681.07 LBP )
● Cost/Month: 22124,1 SEK ( 39,825,633.64 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 184,3671 SEK ( 331,220.24 LBP )
● Cost/Day: 737,47 SEK ( 1,326,681.07 LBP )
● Cost/Month: 22124,1 SEK ( 39,825,633.64 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 184,3671 SEK ( 331,220.24 LBP )
● Cost/Day: 737,47 SEK ( 1,326,681.07 LBP )
● Cost/Month: 22124,1 SEK ( 39,825,633.64 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 184,3671 SEK ( 331,220.24 LBP )
● Cost/Day: 737,47 SEK ( 1,326,681.07 LBP )
● Cost/Month: 22124,1 SEK ( 39,825,633.64 LBP )
Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 15,6296 EUR ( 275,700.75 LBP )
● Cost/Day: 62,52 EUR ( 1,139,563.10 LBP )
● Cost/Month: 1875,6 EUR ( 34,462,593.75 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 15,6296 EUR ( 275,700.75 LBP )
● Cost/Day: 62,52 EUR ( 1,139,563.10 LBP )
● Cost/Month: 1875,6 EUR ( 34,462,593.75 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 15,6296 EUR ( 275,700.75 LBP )
● Cost/Day: 62,52 EUR ( 1,139,563.10 LBP )
● Cost/Month: 1875,6 EUR ( 34,462,593.75 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 15,6296 EUR ( 275,700.75 LBP )
● Cost/Day: 62,52 EUR ( 1,139,563.10 LBP )
● Cost/Month: 1875,6 EUR ( 34,462,593.75 LBP )
Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 195 EGP ( 187,219.50 LBP )
● Cost/Day: 780 EGP ( 748,878.00 LBP )
● Cost/Month: 23400 EGP ( 22,466,340.00 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 195 EGP ( 187,219.50 LBP )
● Cost/Day: 780 EGP ( 748,878.00 LBP )
● Cost/Month: 23400 EGP ( 22,466,340.00 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 195 EGP ( 187,219.50 LBP )
● Cost/Day: 780 EGP ( 748,878.00 LBP )
● Cost/Month: 23400 EGP ( 22,466,340.00 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 195 EGP ( 187,219.50 LBP )
● Cost/Day: 780 EGP ( 748,878.00 LBP )
● Cost/Month: 23400 EGP ( 22,466,340.00 LBP )
Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 10,8907 EUR ( 183,800.50 LBP )
● Cost/Day: 43,56 EUR ( 790,342.15 LBP )
● Cost/Month: 1306,8 EUR ( 24,004,345.30 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 10,8907 EUR ( 183,800.50 LBP )
● Cost/Day: 43,56 EUR ( 790,342.15 LBP )
● Cost/Month: 1306,8 EUR ( 24,004,345.30 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 10,8907 EUR ( 183,800.50 LBP )
● Cost/Day: 43,56 EUR ( 790,342.15 LBP )
● Cost/Month: 1306,8 EUR ( 24,004,345.30 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 10,8907 EUR ( 183,800.50 LBP )
● Cost/Day: 43,56 EUR ( 790,342.15 LBP )
● Cost/Month: 1306,8 EUR ( 24,004,345.30 LBP )
Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 71,531 TRY ( 136,368.99 LBP )
● Cost/Day: 286,12 TRY ( 549,317.34 LBP )
● Cost/Month: 8583,6 TRY ( 16,485,282.27 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 71,531 TRY ( 136,368.99 LBP )
● Cost/Day: 286,12 TRY ( 549,317.34 LBP )
● Cost/Month: 8583,6 TRY ( 16,485,282.27 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 71,531 TRY ( 136,368.99 LBP )
● Cost/Day: 286,12 TRY ( 549,317.34 LBP )
● Cost/Month: 8583,6 TRY ( 16,485,282.27 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 71,531 TRY ( 136,368.99 LBP )
● Cost/Day: 286,12 TRY ( 549,317.34 LBP )
● Cost/Month: 8583,6 TRY ( 16,485,282.27 LBP )
Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 29567,07 LBP ( 29,567.00 LBP )
● Cost/Day: 118268,28 LBP ( 118,268.00 LBP )
● Cost/Month: 3548048,4 LBP ( 3,548,048.00 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 29567,07 LBP ( 29,567.00 LBP )
● Cost/Day: 118268,28 LBP ( 118,268.00 LBP )
● Cost/Month: 3548048,4 LBP ( 3,548,048.00 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 29567,07 LBP ( 29,567.00 LBP )
● Cost/Day: 118268,28 LBP ( 118,268.00 LBP )
● Cost/Month: 3548048,4 LBP ( 3,548,048.00 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 29567,07 LBP ( 29,567.00 LBP )
● Cost/Day: 118268,28 LBP ( 118,268.00 LBP )
● Cost/Month: 3548048,4 LBP ( 3,548,048.00 LBP )
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info